삼성서울병원

Ko En

소아청소년 소화기영양분과 김미진 교수

진료분야
크론병, 궤양성대장염, 복통, 구토, 변비, 설사, 혈변, 헬리코박터감염, 거대결장, 황달, 간염, 간이식, 소아영양, 소아내시경
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 06 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2012.02 충남대학교 의과대학 대학원 의학과 (박사)
2007.02 충남대학교 의과대학 대학원 의학과 (석사)
2003.02 충남대학교 의과대학 졸업

경력

경력
2024.03 ~현재 성균관대학교 의과대학 삼성서울병원 소아청소년과 교수
2023.03 ~ 2024.02 삼성서울병원 전임대우임상교수
2018.04 ~ 2023.02 삼성서울병원 진료부교수
2017.03 ~ 2018.03 충남대학교병원 조교수
2013.03 ~ 2017.02 인제대학교 일산백병원 조교수
2012.09 ~ 2013.02 명지병원 소아청소년과 임상조교수
2009.03 ~ 2012.08 삼성서울병원 소아청소년과 소화기영양 임상강사
2005.03 ~ 2009.02 충남대학교병원 소아청소년과 전공의
2003.03 ~ 2004.02 충남대학교병원 인턴

학회활동

학회활동
2023.10 ~ 현재 대한소아소화기영양학회 재무이사
2009.03 ~ 현재 대한상부위장관 헬리코박터학회 평생회원
2009.03 ~ 현재 대한소아소화기영양학회 평생회원
2009.03 ~ 현재 대한소화기내시경학회 평생회원
2009.03 ~ 현재 대한장연구학회 평생회원
  • FRONT PEDIATR 2024 10.3389/fped.2023.1242009 Long-term outcomes of liver transplantation for biliary atresia and results of policy changes: over 20 years of follow-up experience Kwon, Y; Ahn, YJ; Yang, JH; Kim, ES; Choe, YH; Lee, SH; Kim, MJ
    View PubMed
  • J KOREAN MED SCI 2023 10.3346/jkms.2023.38.e401 A Report on a Nationwide Surveillance System for Pediatric Acute Hepatitis of Unknown Etiology in Korea Lee, KJ; Ko, JS; Park, KY; Kang, KS; Lee, KS; Hong, JA; Kim, SC; Lee, Y; Kang, B; Kim, YB; Kim, HJ; Eun, BW; Cho, HK; Kim, YJ; Kim, MJ; Lee, J; Lee, TJ; Oh, SH; Park, S; Ha Hwang, E; Sohn, S; Lim, JG; Kim, Y; Lee, YJ
    View PubMed
  • BIOMEDICINES 2023 10.3390/biomedicines11092575 Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study Kim, YZ; Kang, B; Kim, ES; Kwon, Y; Choe, YH; Kim, MJ
    View PubMed
  • FRONT MED-LAUSANNE 2023 10.3389/fmed.2023.1231066 Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation Kim, ES; Kwon, Y; Choe, YH; Kim, MJ; Yoo, KH
    View PubMed
  • ANN DERMATOL 2023 10.5021/ad.21.060 Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum Lee, HC; Kwon, Y; Kim, ES; Ahn, S; Choe, YH; Kim, MJ
    View PubMed
  • THER ADV GASTROENTER 2023 10.1177/17562848231170948 Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn's disease patients with secondary loss of response Kim, ES; Kwon, Y; Choe, YH; Kim, MJ
    View PubMed
  • J KOREAN MED SCI 2023 10.3346/jkms.2023.38.e71 The Changes in Respiratory and Enteric Adenovirus Epidemiology in Korea From 2017 to June 2022 Kim, KR; Won, J; Kim, H; Kim, BI; Kim, MJ; Kim, JY; Gwack, J; Kim, YJ
    View PubMed
  • FRONT IMMUNOL 2022 10.3389/fimmu.2022.996875 Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission Kwon, Y; Kim, YZ; Choe, YH; Kim, MJ
    View PubMed
  • BIOMEDICINES 2022 10.3390/biomedicines10102372 Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn's Disease Kwon, Y; Kim, ES; Kim, YZ; Choe, YH; Kim, MJ
    View PubMed
  • GUT LIVER 2022 10.5009/gnl210488 Comparison between Pediatric Crohn's Disease and Ulcerative Colitis at Diagnosis in Korea: Results from a Multicenter, Registry-Based, Inception Cohort Study Park, S; Kang, B; Kim, S; Choi, S; Suh, HR; Kim, ES; Park, JH; Kim, MJ; Choe, YH; Lee, YJ; Park, JH; Ryoo, E; Koh, H; Choe, BH
    View PubMed
  • J KOREAN MED SCI 2022 10.3346/jkms.2022.37.e282 Vedolizumab Is Safe and Efficacious for the Treatment of Pediatric-Onset Inflammatory Bowel Disease Patients Who Fail a Primary Biologic Agent Choi, S; Kim, ES; Kwon, Y; Kim, MJ; Choe, YH; Choe, BH; Kang, B
    View PubMed
  • THER DRUG MONIT 2022 10.1097/FTD.0000000000000976 Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn's Disease Kwon, Y; Kang, B; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • WORLD J GASTROENTERO 2022 10.3748/wjg.v28.i28.3666 How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study Kwon, Y; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • FRONT PEDIATR 2022 10.3389/fped.2022.853019 Increased Demand for Therapeutic Drugs in Pediatric Ulcerative Colitis Patients With Extraintestinal Manifestations Kwon, Y; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • FRONT PEDIATR 2022 10.3389/fped.2022.846273 Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children Kwon, Y; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-021-04304-6 Discontinuation of Azathioprine could be considered in pediatric patients with Crohn's disease who have sustained clinical and deep remission Jeong, TJ; Kim, ES; Kwon, Y; Kim, S; Seo, SW; Choe, YH; Kim, MJ
    View PubMed
  • ALIMENT PHARM THER 2022 10.1111/apt.16769 NUDT15 intermediate metabolisers are associated with lower loss of response in paediatric Crohn's disease patients treated by combination treatment with infliximab and azathioprine Kim, ES; Choi, S; Choi, SY; Park, JH; Choe, BH; Lee, SY; Kim, MJ; Choe, YH; Kang, B
    View PubMed
  • GUT LIVER 2021 10.5009/gnl20212 Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn's Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage Kim, MJ; Kim, E; Kang, B; Lee, Y; Kang, ES; Choe, YH
    View PubMed
  • FRONT IMMUNOL 2021 10.3389/fimmu.2021.698721 Needs for Increased Awareness of Gastrointestinal Manifestations in Patients With Human Inborn Errors of Immunity Kim, ES; Kim, D; Yoon, Y; Kwon, Y; Park, S; Kim, J; Ahn, KM; Ahn, S; Choe, YH; Kim, YJ; Kim, MJ
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.7.608 Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy Kim, MJ; Kim, E; Kang, B; Choe, YH
    View PubMed
  • J PEDIATR GASTR NUTR 2021 10.1097/MPG.0000000000003070 Therapeutic Drug Monitoring of Adalimumab During Long-term Follow-up in Paediatric Patients With Crohn Disease Kim1, MJ; Kim, E; Kang, B; Choe, YH
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.5.470 Therapeutic Lymphatic Embolization in Pediatric Primary Intestinal Lymphangiectasia Kwon1, Y; Kim, ES; Choe, YH; Hyun, D; Kim, MJ
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-84766-w COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity Kim1, ES; Kwon, Y; Choe, YH; Kim, MJ
    View PubMed
  • BMC PEDIATR 2021 10.1186/s12887-020-02447-5 Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature Kwon1, Y; Kim, ES; Choe, YH; Kim, MJ
    View PubMed
  • PHARMACOGEN PERS MED 2020 10.2147/PGPM.S279446 The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn's Disease Ha1, C; Kim, ES; Kwon, Y; Choe, YH; Kim, MJ; Lee, SY
    View PubMed
  • SCI REP-UK 2020 10.1038/s41598-020-75938-1 Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients Kim1, ES; Kwon, Y; Choe, YH; Kim, MJ
    View PubMed
  • FRONT MICROBIOL 2020 10.3389/fmicb.2020.02099 Delayed Establishment of Gut Microbiota in Infants Delivered by Cesarean Section Kim1, G; Bae, J; Kim, MJ; Kwon, H; Park, G; Kim, SJ; Choe, YH; Kim, J; Park, SH; Choe, BH; Shin, H; Kang, B
    View PubMed
  • INDIAN PEDIATR 2019 10.1007/s13312-019-1649-5 Correlation of Dickkopf-1 with Inflammation in Crohn Disease Kim1, MJ; Choe, YH
    View PubMed